SD 655 —
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 193rd Legislature (2023-2024). It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
In plain language
The bill addresses transparency in pharmaceutical pricing.
This bill requires clearer information about drug pricing from pharmaceutical companies. It aims to help consumers understand the costs associated with medications.
What this means for you
- Consumers: This means you will have better access to drug pricing information, allowing for more informed healthcare choices.
Sponsorship breakdown
Export CSV (upgrade) →0 sponsors · 0 co-sponsors · 204 not signed on
Sponsors (0)
None.
Co-sponsors (0)
None.
Not signed on (204)
204 members have not signed on to this bill.
Show all 204 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Frequently asked questions
- What is the current status of SD 655?
- This bill died with 193rd Legislature (2023-2024). It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SD 655?
- Track SD 655 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SD 655
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SD 655
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →